These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8068599)

  • 21. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
    Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F
    Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
    Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG
    Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a significant proportion of patients with end-stage renal disease.
    Parsons DS; Reaveley DA; Pavitt DV; Misra M; Brown EA
    Nephrol Dial Transplant; 2003 Sep; 18(9):1848-53. PubMed ID: 12937234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with hyperthyroidism.
    Klausen IC; Hegedüs L; Hansen PS; Nielsen FE; Gerdes LU; Faergeman O
    J Mol Med (Berl); 1995 Jan; 73(1):41-6. PubMed ID: 7633941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
    Saku K; Zhang B; Liu R; Shirai K; Arakawa K
    Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
    Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J
    Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA; Morrisett JD; Boerwinkle E; Hutchinson R; Patsch W
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
    J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia.
    Bartens W; Rader DJ; Talley G; Brewer HB
    Atherosclerosis; 1994 Aug; 108(2):149-7. PubMed ID: 7980714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
    Bartens W; Nauck M; Schollmeyer P; Wanner C
    Perit Dial Int; 1996; 16(1):27-33. PubMed ID: 8616169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) in health and disease.
    Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H
    Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
    Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
    Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further characterization of the plasma lipoprotein(a) distribution.
    Craig W; Poulin S; Bostom A; Eaton C; Laurino J; Ledue T; Ritchie R
    J Clin Lab Anal; 1995; 9(6):392-6. PubMed ID: 8587008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients.
    Azrolan N; Brown CD; Thomas L; Hayek T; Zhao ZH; Roberts KG; Scheiner C; Friedman EA
    Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentanucleotide repeat and size polymorphisms in the apolipoprotein(a) gene are associated with the lipoprotein(a) concentration in chronic hemodialysis patients.
    Tanaka M; Yanagi H; Ando R; Kurihara S; Hirano C; Kobayashi K; Kikuchi S; Hamaguchi H; Tsuchiya S; Tomura S
    Nephron; 1999; 81(4):414-20. PubMed ID: 10095177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.
    Kerschdorfer L; König P; Neyer U; Bösmüller C; Lhotta K; Auinger M; Hohenegger M; Riegler P; Margreiter R; Utermann G; Dieplinger H; Kronenberg F
    Atherosclerosis; 1999 Jun; 144(2):381-91. PubMed ID: 10407499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein (a) and apolipoprotein (a) phenotypes in healthy Macedonian children.
    Tosheska K; Labudovic D; Alabakovska S; Handziski Z; Spiroski M; Todorova B
    Bratisl Lek Listy; 2007; 108(4-5):179-83. PubMed ID: 17694801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.